|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenues | |||||
| Products | |||||
| Service | |||||
| Total net revenues | |||||
| Cost of revenues | |||||
| Fulfillment | |||||
| Marketing | |||||
| Research and development | |||||
| General and administrative | |||||
| Impairment of goodwill | |||||
| Impairment of long-lived assets | |||||
| Gain on sale of development properties | |||||
| Income from operations | |||||
| Other income/(expense) | |||||
| Share of results of equity investees | |||||
| Interest expense | |||||
| Others, net | |||||
| Income before tax | |||||
| Income tax expenses | |||||
| Net income | |||||
| Other comprehensive income/(loss): | |||||
| Foreign currency translation adjustments | |||||
| Total comprehensive income | |||||
| Total comprehensive (loss)/income attributable to non-controlling interests shareholders | |||||
| Total comprehensive income attributable to mezzanine equity classified as non-controlling interests shareholders | |||||
| Total comprehensive income attributable to the Company's ordinary shareholders | |||||
| Net income/(loss) per share | |||||
| Basic | |||||
| Basic | |||||
| Diluted | |||||
| Diluted | |||||
| Weighted average number of shares | |||||
| Basic | |||||
| Diluted | |||||
| Net (loss)/income attributable to non-controlling interests shareholders | |||||
| Net income attributable to the Company's ordinary shareholders |
Loading...